Toviaz - 0069-0242-68 - (fesoterodine fumarate)

Alphabetical Index


Drug Information of Toviaz

Product NDC: 0069-0242
Proprietary Name: Toviaz
Non Proprietary Name: fesoterodine fumarate
Active Ingredient(s): 4    mg/1 & nbsp;   fesoterodine fumarate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Toviaz

Product NDC: 0069-0242
Labeler Name: Pfizer Laboratories Div Pfizer Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022030
Marketing Category: NDA
Start Marketing Date: 20081031

Package Information of Toviaz

Package NDC: 0069-0242-68
Package Description: 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0242-68)

NDC Information of Toviaz

NDC Code 0069-0242-68
Proprietary Name Toviaz
Package Description 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0242-68)
Product NDC 0069-0242
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name fesoterodine fumarate
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20081031
Marketing Category Name NDA
Labeler Name Pfizer Laboratories Div Pfizer Inc
Substance Name FESOTERODINE FUMARATE
Strength Number 4
Strength Unit mg/1
Pharmaceutical Classes

Complete Information of Toviaz


General Information